Firm at a glance
BGH Capital is a platform private equity firm founded in 2017 and headquartered in Melbourne, VIC, Australia, per its own website [S1]. The firm reported approximately $6.8 billion in funds under management as of April 2026 [S2].
What they buy
BGH Capital appears to pursue acquisitions across the Asia-Pacific region, with recent activity indicating interest in healthcare and pharmaceutical operations. The firm’s January 2026 acquisition of Aspen Pharmacare’s Asia-Pacific business suggests a focus on established regional platforms with multinational reach [S3]. The firm’s current fund vintage dates to 2022 [S1].
Portfolio
Public sources available as of April 2026 did not surface a comprehensive list of current portfolio companies beyond recent transaction activity.
Recent activity (last 24 months)
* **January 2026**: Acquired Aspen Pharmacare Asia-Pacific Business [S3]
How this firm fits a seller
BGH Capital operates as an Australia-based platform investor with demonstrated capacity to execute cross-border transactions in the Asia-Pacific healthcare sector. The firm’s acquisition of a multinational pharmaceutical business in early 2026 suggests capability to handle complex regional carve-outs and established operating platforms. For owner-operators in healthcare or related sectors with Asia-Pacific operations, BGH represents a regionally focused buyer with substantial capital resources. The firm’s 2022 fund vintage indicates active deployment capacity through approximately 2027-2028 based on typical private equity fund lifecycles.
Sources
[S1] https://bghcapital.com/About (as of 2026-04-20)
[S2] https://bghcapital.com (as of 2026-04-20)
[S3] https://dabafinance.com/en/news/aspen-pharmacare-apac-sale-bgh-capital (as of 2026-01)
Frequently asked questions
Does BGH Capital buy healthcare businesses?
Yes, BGH Capital has demonstrated investment activity in the healthcare sector. The firm acquired Aspen Pharmacare’s Asia-Pacific business in January 2026, indicating active interest in pharmaceutical and healthcare platforms operating across the region [S3].
What companies has BGH Capital acquired recently?
The most recent publicly reported transaction was BGH Capital’s acquisition of Aspen Pharmacare’s Asia-Pacific business in January 2026 [S3]. Additional portfolio company details were not available in public sources as of April 2026.
Where is BGH Capital based and how big is the firm?
BGH Capital is based in Melbourne, VIC, Australia [S1]. The firm reported approximately $6.8 billion in funds under management as of April 2026 [S2], with its current fund vintage dating to 2022 [S1].
Is BGH Capital still actively acquiring?
Yes, BGH Capital appears to be actively acquiring based on its January 2026 transaction involving Aspen Pharmacare’s Asia-Pacific business [S3]. With a 2022 fund vintage [S1], the firm is likely in active deployment phase through the mid-to-late 2020s.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.